Cholangiocarcinoma-UK, an affiliate of the British Association for Study of Liver Disease (BASL), is a multi-disciplinary Special Interest Group (SIG) of clinicians, scientists and patient advocates whose purpose is to facilitate collaborative research, enhance service development and raise awareness of Cholangiocarcinoma.
Aims of Cholangiocarcinoma UK
• Be the recognised leading authority on Cholangiocarcinoma in the UK
• Become affiliated to other relevant major national organisations e.g. BASO, BSG
• Facilitate basic science and clinical research as well as sample collection, including for biomarker development
• Improve the pathway to collaborative clinical trials and opportunities for research funding
• Update national guidelines and advise on policy and best practice
• Optimise and standardise clinical management across the country
• Monitor epidemiological trends accurately.
|Chair||Professor Shahid Khan||Imperial College, London|
|Secretary||Professor Derek Manas||Freeman Hospital, Newcastle upon Tyne|
|Patient advocate||Helen Morement||AMMF – The Cholangiocarcinoma Charity|
|Basic science representatives||Professor David Bates||University of Nottingham|
|Dr Luke Boulter||MRC Human Genetics Unit, Edinburgh|
|Dr Chiara Braconi||University of Glasgow|
|Dr Sheela Jayaraman||University of Birmingham|
|Endoscopy representative||Professor Steve Pereira||University College / Royal Free Hospital, London|
|Hepatology representative||Dr Simon Rushbrook||Norfolk & Norwich University Hospitals|
|Clinical oncology representative||Professor Maria Hawkins||University College, London|
|Medical oncology representatives||Professor John Bridgewater||University College, London|
|Professor Juan Valle||Christie NHS Foundation Trust / University of Manchester|
|Pathology representative||Dr Tim Kendall||University of Edinburgh / Royal Infirmary Edinburgh|
|Surgery representatives||Professor Brian Davidson||Royal Free Hospital, London|
|Professor Nigel Heaton||King's College Hospital, London|
|Mr Hassan Malik||Aintree University Hospital|
|Trainee representatives||Dr Pilar Acedo||University College, London|
|Dr Leonard Marc Quinn||University of Liverpool|
Annual report 2018-19 - Download Annual report_2018-19_CCA-UK.pdf.
1st meeting - 7 December 2018
Welcome presentation, Shahid Khan, St Mary’s Hospital, London - Download Welcome.pdf
Presentation on the patient/healthcare professional partnership, Helen Morement, AMMF - Download The patient_healthcare professional partnership.pdf
Presentation on Epidemiology and aetiology: What we don’t know & how can we find out, Shahid Khan, St Mary’s Hospital, London - Download Epidemiology and aetiology_What we dont know and how we can find out.pdf
Presentation on Ensuring quality: Centres of “excellence/expertise”?, Hassan Malik, Aintree University Hospital Download Ensuring quality_Centres of excellence and expertise.pdf
Presentation on Medical oncology: The unmet needs and how we meet them, John Bridgewater, UCL & Juan Valle, Christie NHS Foundation Trust - Download Medical oncology_The unmet needs and how we meet them.pdf
Presentation on Clinical oncology: Establishing novel roles in CCA therapy, Maria Hawkins, University of Oxford - Download Clinical oncology_Establishing novel roles in CCA therapy.pdf
2nd meeting - 14 November 2019
Presentation on Cholangiocarcinoma and liver fluke infection in Lao PDR, Peter Odermatt, Swiss Tropical and Public Health Institute - Download CCA and Liver Fluke Infection in Lao_P Odermatt.pdf
Presentation on Universal tumour antigens in primary liver cancers: Cholangiocarcinoma and Hepatocellular carcinoma are differentUniversal tumour antigens in primary liver cancers: Cholangiocarcinoma and Hepatocellular carcinoma are different, Ollie Rupar, University of Plymouth - Download Universal tumour antigens in primary liver cancers_Ollie Rupar.pdf
Presentation on Single molecule detection of osteopontin in nanopores using DNA molecular carriers, Micol Damiani, Imperial College London - Download Single molecule detection of osteopontin in nanopores_M Damiani.pdf
Presentation on the investigation of virus-driven intrahepatic Cholangiocarcinoma through dysregulated hepatic differentiation, Alex Kilvington, University of Leeds - Download Virus-Driven Intrahepatic CCA_A Kilvington.pdf
Presentation on the role of mesenchymalcells in Cholangiocarcinoma, Mireia Sueca Comes, University of Nottingham - Download Role of Mesenchymal Cells in CCA_M Sueca-Comes.pdf
Presentation on non-coding RNAs and the biology underpinning potential new precision medicines in Cholangiocarcinoma, Chiara Braconi, University of Glasgow - Download RNAs and biology underpinning potential new precision medicines_C Braconi 1.pdf
Presentation on Delphi process on next key questions in basic science of Cholangiocarcinoma, Shahid Khan, Imperial College London - Download Clinical and Research Priorities in CCA_S Khan.pdf
The AMMF is represented on the CCA-UK Steering Committee and is the UK’s only cholangiocarcinoma charity - http://ammf.org.uk/.
Global CCA Alliance
The Global Cholangiocarcinoma Alliance (GCA) has united to establish a global voice in CCA through community collaborations. The GCA has a shared vision to raise the awareness of CCA, in order to improve prevention, survival and the quality of life of CCA patients globally. CCA-UK is a partner in this Alliance. For more information, visit https://globalccaalliance.com/en.
CCA-UK workshop, 11 June 2020 - STATUS UPDATE
CCA-UK is due to hold a clinical themed workshop at the UK Oncology Forum annual conference in Birmingham. The workshop is due to take place on the morning of Thursday 11 June 2020.
Please note the following information from the UK Oncology Forum organisers. Due to the Covid-19 virus, the UK Oncology Forum Faculty have decided to make a decision about the 2020 conference early/mid-April. They are currently liaising with the venue, the ICC. If the situation escalates they are NOT looking to cancel, but to postpone the meeting (possibly to September more details to follow). The venue has a specific policy/increased measures in place for the COVID-19 situation. You many continue to register for the CCA-UK workshop at this stage. This is via the UK Oncology Forum website, see details below.
The UK Oncology Forum annual conference runs from 11-12 June. Both the CCA-UK workshop and UK Oncology Forum annual conference are free to attend. The conference is CPD accredited.
Anyone wishing to attend the CCA-UK workshop will be expected to stay on for the whole of day one of the annual conference. Registration is via the UK Oncology Forum - https://oncology-forum.co.uk/register/. When registering please ensure you choose the CCA-UK workshop option under the section UK Oncology Forum and Cancer Collaboration. Delegates are of course welcome to attend both days of the annual conference.
Workshop invite - Download 2020 OF Invitation CCA-UK.pdf.
CCA-UK Annual Meeting, 22 November 2020
The next CCA-UK Annual Meeting will be held on Sunday 22nd November 2020. It will be hosted at the BASO Annual Scientific Meeting, which will be held on 22-23 November 2020 at The Law Society, 113 Chancery Lane, London WC2A 1PL. Further details, including how to register, will follow.